A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
| Image |  |
|---|---|
| Description | scientific article published on 30 August 2013 |
| Author/s |
author: Kevin C. Maki Judith Johnson |
| Publication date | August 30, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |